Sertraline and vaginal bleeding - A possible association [3]

Journal of the American Geriatrics Society

Volumn 50, Issue 1, 2002, Pages 200-201

  Smith, Michael ^a   Robinson, Dave ^a  

^a St Joseph's Medical Center Stockton   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CITALOPRAM; FLUOXETINE; FLUVOXAMINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

AGED; CASE REPORT; DIGESTIVE SYSTEM FUNCTION DISORDER; DRUG EFFECT; DRUG SAFETY; FEMALE; HEADACHE; HUMAN; LETTER; PARESTHESIA; SEXUAL DYSFUNCTION; VAGINA BLEEDING;

AGED; ALCOHOLISM; FEMALE; HUMANS; SEROTONIN UPTAKE INHIBITORS; SERTRALINE; UTERINE HEMORRHAGE;

EID: 0036140694     PISSN: 00028614     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1532-5415.2002.50032.x     Document Type: Letter

References (7)

1. Selective serotonin-reuptake inhibitors: An update
2. Risk of hemorrhage with the use of fluoxetine (Prozac) or fluvoxamine
3. Prolonged bleeding time in a patient treated with sertraline
4. Selective serotonin reuptake inhibitors: Infrequent medical adverse effects
5. Paroxetine decreases platelet serotonin storage and platelet function in human beings
6. Potential vascular and bleeding complications of treatment with selective serotonin reuptake inhibitors
7. The effect of selective serotonin-reuptake inhibitors in blood coagulation